- Company Overview for FORGE BIO NO.3C NOMINEE A LIMITED (14217542)
- Filing history for FORGE BIO NO.3C NOMINEE A LIMITED (14217542)
- People for FORGE BIO NO.3C NOMINEE A LIMITED (14217542)
- More for FORGE BIO NO.3C NOMINEE A LIMITED (14217542)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
25 Jul 2024 | RESOLUTIONS |
Resolutions
|
|
25 Jul 2024 | MA | Memorandum and Articles of Association | |
16 Jul 2024 | CS01 | Confirmation statement made on 5 July 2024 with updates | |
03 Apr 2024 | AA | Total exemption full accounts made up to 30 September 2023 | |
10 Jul 2023 | CS01 | Confirmation statement made on 5 July 2023 with no updates | |
25 Apr 2023 | AP01 | Appointment of Jennifer Elizabeth Lambkin as a director on 24 April 2023 | |
25 Apr 2023 | TM01 | Termination of appointment of Rinaldo Enrico Marcoz as a director on 24 April 2023 | |
01 Aug 2022 | AA01 | Current accounting period extended from 31 July 2023 to 30 September 2023 | |
21 Jul 2022 | PSC05 | Change of details for Forge Bio (Gsk) Master Nominee Holdco Limited as a person with significant control on 20 July 2022 | |
20 Jul 2022 | CERTNM |
Company name changed forge bio (gsk) no.3C nominee a LIMITED\certificate issued on 20/07/22
|
|
06 Jul 2022 | NEWINC |
Incorporation
Statement of capital on 2022-07-06
|